Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Modeling in Therapy

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...

Post-traumatic Stress Disorder

Post-traumatic Stress Disorder

Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Interpersonal Psychotherapy

Interpersonal Psychotherapy

Interpersonal psychotherapy (IPT) is a structured, time-limited therapeutic approach initially developed to treat depression. It integrates key concepts from psychodynamic, humanistic, and cognitive-behavioral therapies, making it a uniquely eclectic framework. The therapy is rooted in the interpersonal theories of Adolph Meyer and Harry Stack Sullivan, as well as John Bowlby's attachment theory, and focuses on the interplay between interpersonal relationships and emotional well-being.

Electroconvulsive Therapy

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Decoding post-transcriptional regulatory networks by RNA-linked CRISPR screening in human cells.

Nature methods·2025

Same author

Decoding RNA Metabolism by RNA-linked CRISPR Screening in Human Cells.

bioRxiv : the preprint server for biology·2024

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 12, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

MDMA-Assisted Psychotherapy for PTSD: A Systematic Review of Randomized Control Trials.

Barbara Brett¹, Christine Bynum¹

¹Psychology Department, Colorado State University - Pueblo, Pueblo, CO, USA.

Journal of Psychoactive Drugs

|November 5, 2025

Summary

MDMA-assisted psychotherapy (MDMA-AT) shows significant promise for treating posttraumatic stress disorder (PTSD), with most participants no longer meeting criteria post-treatment. Further research is needed for FDA approval.

Keywords:

Breakthrough therapy MAPS MDMA MDMA-assisted psychotherapy PTSD post-traumatic stress disorder

More Related Videos

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Published on: November 25, 2025

Related Experiment Videos

Last Updated: Jan 12, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Published on: November 25, 2025

Area of Science:

Psychiatry and Mental Health
Pharmacology
Clinical Trials

Background:

Posttraumatic stress disorder (PTSD) is a chronic mental health condition with limited effective treatments.
3,4-methylenedioxymethamphethamine (MDMA)-assisted psychotherapy (MDMA-AT) has demonstrated potential in clinical trials for PTSD symptom reduction.
The FDA's recent vote against recommending MDMA-AT highlights ongoing concerns regarding its risk-benefit profile.

Purpose of the Study:

To systematically review randomized controlled trials (RCTs) evaluating the safety and efficacy of MDMA-AT in adults with PTSD.
To assess the current evidence base to inform potential FDA approval for MDMA-AT.
To synthesize findings on PTSD symptom reduction and treatment tolerability.

Main Methods:

Systematic review of seven randomized controlled trials (RCTs) involving 280 adult participants with PTSD.
Independent data review focusing on PTSD symptom reduction and safety outcomes.
Exclusion of two retracted articles from the analysis.

Main Results:

Five of six efficacy studies (83.3%) reported significantly improved PTSD symptoms with MDMA-AT compared to placebo.
Post-treatment, 41.7%–85.7% of participants receiving MDMA-AT no longer met PTSD criteria, versus 25.0%–33.3% for placebo.
The MDMA-AT treatment was generally well-tolerated by participants.

Conclusions:

MDMA-assisted psychotherapy (MDMA-AT) shows potential as a viable treatment for PTSD symptoms.
Evidence from RCTs supports the efficacy and safety of MDMA-AT.
Additional research with rigorous ethical oversight is recommended to guide FDA approval decisions.